Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

ADV7103

Aliases
Potassium Citrate and Potassium Bicarbonate
Name
POTASSIUM CITRATE
INN Name
Potassium Citrate
FDA Approved
Yes

4 clinical trials

4 organizations

4 indications

2 documents

Indication
Acidosis
Indication
Renal Tubular
Indication
Distal RTA
Indication
Cystinuria
Clinical trial
A Phase 3B Open-Label Extension Of Study B23CS (ARENA 2) Evaluating The Continued Safety And Efficacy Of ADV7103 In Subjects With Primary Distal Renal Tubular Acidosis
Status: Withdrawn, Estimated PCD: 2025-01-01
Clinical trial
A Phase 3 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Withdrawal Study Evaluating ADV7103 In Pediatric and Adult Subjects With Distal Renal Tubular Acidosis (dRTA)
Status: Terminated, Estimated PCD: 2023-12-20
Clinical trial
Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Status: Withdrawn, Estimated PCD: 2025-06-01
Clinical trial
A Multicentre, Randomized, Controlled Versus Placebo, Double-blinded, 4 Parallel Arms, Dose-ranging Main Study, to Evaluate the Efficacy, Safety and Tolerability and Acceptability of Repeated Doses of ADV7103, After 7 Days of Treatment, in Patients With Cystinuria, and an Efficacy and Safety Exploratory Study in the Youngest Children.
Status: Not yet recruiting, Estimated PCD: 2025-05-01
Document
DailyMed Label: POTASSIUM CITRATE
Organization
XLCare Pharmaceuticals, Inc.
Organization
ANI Pharmaceuticals, Inc.
Document
DailyMed Label: Potassium Citrate
Organization
bryant ranch prepack
Organization
Upsher-Smith Laboratories, LLC